Literature DB >> 1957757

Correlation between resting ST segment depression, exercise testing, coronary angiography, and long-term prognosis.

C P Miranda1, K G Lehmann, V F Froelicher.   

Abstract

Resting ST segment depression has been identified as a marker for adverse cardiac events in patients with and without known coronary artery disease. To correlate this with exercise testing, coronary angiography, and how it impacts on long-term prognosis, a retrospective study was performed on 476 patients, of whom 223 had no clinical or electrocardiographic evidence of prior myocardial infarction while 253 were survivors of an infarction. All patients performed a standard exercise test and underwent diagnostic coronary angiography within an average of 32 days of their exercise test (range 0 to 90 days). Exclusions were women, those with left bundle branch block, left ventricular hypertrophy, use of digoxin, previous revascularization procedures, or significant valvular or congenital heart disease. Long-term follow-up was carried out for an average of 45 months (+/- 17). Of the patients without prior infarction, 23 (10%) had persistent resting ST segment depression, and of those with a prior history of infarction, 37 (15%) also had resting ST segment depression. Patients with resting ST segment depression and no prior myocardial infarction had a higher prevalence of severe coronary disease (three-vessel and/or left main) (30%) than those without resting ST segment depression (16%) (95% confidence interval [CI] for observed difference -5.0% to 33.9%, p = 0.12). The criterion of greater than or equal to 2 mm of additional exercise-induced ST segment depression was a particularly useful marker in these patients for the diagnosis of any coronary disease (likelihood ratio 3.35, 95% CI 0.56 to 19.93, p = 0.06). Patients with resting ST segment depression and a prior myocardial infarction had a 2.5 times higher prevalence of severe coronary artery disease compared with patients without resting ST segment depression (43% versus 17% prevalence, respectively, 95% CI for observed difference 9.38% to 42.8%, p less than 0.001) and also had larger left ventricles postinfarction (left ventricular end-diastolic volume index 102 ml/m2 compared with 96 ml/m2, p less than 0.001).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1957757     DOI: 10.1016/0002-8703(91)90279-q

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Investigation and management of stable angina: revised guidelines 1998. Joint Working Party of the British Cardiac Society and Royal College of Physicians of London.

Authors:  D de Bono
Journal:  Heart       Date:  1999-05       Impact factor: 5.994

2.  Prognostic value of myocardial perfusion SPECT versus exercise electrocardiography in patients with ST-segment depression on resting electrocardiography.

Authors:  Andrea De Lorenzo; Rory Hachamovitch; Xingping Kang; Heidi Gransar; Maria G Sciammarella; Sean W Hayes; John D Friedman; Ishac Cohen; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

3.  Cardiac catheter complications related to left main stem disease.

Authors:  J D Kovac; D P de Bono
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

Review 4.  Contemporary management of chronic stable angina.

Authors:  A D Staniforth
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Significance of lead strength during exercise testing.

Authors:  George Polizos; Myrvin H Ellestad
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-01       Impact factor: 1.468

Review 6.  North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management angina. North of England Stable Angina Guideline Development Group.

Authors: 
Journal:  BMJ       Date:  1996-03-30

Review 7.  Overview of exercise stress testing.

Authors:  Suleiman M Kharabsheh; Abdulaziz Al-Sugair; Jehad Al-Buraiki; Juman Al-Farhan
Journal:  Ann Saudi Med       Date:  2006 Jan-Feb       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.